Excessive pap smears due to opportunistic cervical cancer screening

The study aimed to analyze the Pap smears carried Out for cervical cancer screening according to Ministry of Health guidelines. All smear tests carried out within the public health system in Campinas in 2003 were analyzed. All tests that did not conform to the guidelines were considered excessive. The guidelines recommend screening once every three years for all women aged 25 to 59 after they have received two negative smears. This study showed that the majority of women initiated screening prior to 25 years of age and the periodicity was predominantly annual, followed by biannual tests. In conclusion, 63.4% of tests were excessive. The screening coverage was 14.76%, but if all the tests had been performed as recommended, the final coverage over three years Could have reached 65.4%. Thus it is possible to increase the coverage with the available resources since the screening works like ail organized program.

Cervical cancer screening; Vaginal smear; Public health administration; Women’s healthcare; Screening programs

[1] Brasil Ministério da Saúde. Programa Nacional de Controle do Câncer do Colo do Útero e de Mama - Viva Mulher. Rio de Janeiro (Brasil): Instituto Nacional de Câncer. [cited 2007 Feb 24]. Available from: http://www.inca.gov.br/prevencao/programas/viva_mulher/

[2] Ferlay J., Bray F., Pisani P., Parkin D.M., GLOBOCAN 2000: “Cancer incidence, mortality and prevalence worldwide”. Version 1.0., Lyon; IARC Press; 2001. (IARC Cancer Base No. 5).

[3] Parkin D.M., Bray F.I., Devesa S.S.: “Cancer burden in the year 2000. The global picture”. Eur. J. Cancer, 2001, 37 (suppl. 8), S4.

[4] van Ballegooijen M., Marle E., Patnick J., Lynge E., Arbyn M., Anttila A. et al.: “Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness”. Eur. J. Cancer, 2000, 36, 2177.

[5] Atalah E., Urteaga C., Rebolledo A., Villegas R.A., Medina E., Csendes A.: “Alimentación, tabaquismo e historia reproductiva como factores de riesgo del cáncer de cuello del útero. [Diet,smoking and reproductive history as risk factor for cervical cancer]”. Rev. Med. Chile, 2001, 129, 597.

[6] Kjellberg L., Hallmans G., Johansson R., Bergman F., Wadell G., Angström T. et al.: “Smoking, diet, pregnancy, and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection”. Br. J. Cancer, 2000, 82, 1332.

[7] Brasil Ministério da Saúde. Prevenção do Câncer do Colo do Útero. Manual Técnico para Laboratórios. Brasília, DF: Ministério da Saúde; 2002.

[8] Elovainio L., Nieminen P., Miller A.B.: “Impact of cancer screening on women’s health”. Int. J. Gynaecol. Obstet., 1997, 58, 137.

[9] Brasil Ministério da Saúde. Atlas de mortalidade por cancer no Brasil 1979-1999. Rio de Janeiro (Brasil): Instituto Nacional de Câncer. [cited 2007 Feb 24]. Available from: http://www.inca.gov.br/atlas/docs/seriestemp_BR.pdf (Série temporal das taxas de mortalidade, brutas e ajustadas por idade pelas populações mundial e brasileira, para topografias selecionadas, entre 1979 e 1999).

[10] Solomon D., Davey D., Kurman R., Moriarty A., O’Connor D., Prey M. et al.: “Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology”. JAMA, 2002, 287, 2114.

[11] Wright V.C., Riopelle M.A.: “Age at beginning of coitus versus chronologic age as a basis for Papanicolaou smear screening: An analysis of 747 cases of preinvasive disease”. Am. J. Obstet. Gynecol., 1984, 149, 824.

[12] Östör A.G.: “Natural history of cervical intraepithelial neoplasia: a critical review”. Int. J. Gynecol. Pathol., 1993, 12, 186.

[13] d’Ottaviano-Morelli M.G., Zeferino L., Cecatti J.G., Terrabuio D.R., Martinez E.Z.: “Prevalence of cervical intraepithelial neoplasia and invasive carcinoma based on cytological screening in the region of Campinas, Brazil”. Cad. Saude Publica, 2004, 20, 153.

[14] I.A.R.C. working group on evaluation of cervical cancer screening programmes: “Screening for squamous cervical cancer:duration of low risk after negative results of cervical cytology and its implications for screening policies”. Br. Med. J. (Clin. Res. Ed.), 1986, 293, 659.

[15] Datta N.R., Pasricha R., Singh U., Srivastava A.: “Predictors of survival end points in patients with cancer of the cervix on longterm follow-up: inferences and implications from an audit of patients treated with a specific radiotherapy protocol”. Clin. Oncol. (R. Coll. Radiol.), 2004, 16, 536.

[16] Amaral R.G., Zeferino L.C., Hardy E., Westin M.C., Martinez E.Z., Montemor E.B.: “Quality assurance in cervical smears: 100% rapid rescreening vs 10% random rescreening”. Acta Cytol., 2005, 49, 244.

[17] Zeferino L.C., Pinotti J.A., Jorge J.P., Westin M.C., Tambascia J.K., Montemor E.B.: “Organization of cervical cancer screening in Campinas and surrounding region, Sao Paulo State, Brazil”. Cad Saude Publica, 2006, 22, 1909.